by Lucas Carter
Eric Schuur, co-founder and CEO of HepaTx, discusses the science behind groundbreaking stem cell therapies. We also explore the potential of such therapies to change how we fight all diseases.
David Mack, co-founder and CEO of PMV Pharma, gives us an in-depth look at the cancer-stopping power of P53. We discuss emerging cancer therapies, small-molecule chemistry, and future drug targets. Plus, fun stories from the invention of PCR.